Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Anthony@Pacific & TRUTHSEEKER Expose Crims & Scammers!!! -- Ignore unavailable to you. Want to Upgrade?

To: ravenseye who wrote (372)	2/27/2006 11:37:08 AM
From: StockDung	Read Replies (2) \| Respond to of 5673

SEC's Cox comments on reports of journalist subpoenas Mon Feb 27, 2006 10:07 AM ET By Karey Wutkowski WASHINGTON, Feb 27 (Reuters) - The head of the U.S. Securities and Exchange Commission on Monday responded to reports that the agency had subpoenaed two journalists for information in a stock manipulation investigation, saying the issuance of a subpoena is highly unusual. "Until the appearance of media reports this weekend, neither the Chairman of the SEC, the General Counsel, the Office of Public Affairs, nor any Commissioner was apprised of or consulted in connection with a decision to take such an extraordinary step," SEC Chairman Christopher Cox said in a statement. "The sensitive issues that such a subpoena raises are of sufficient importance that they should, and will be, considered and decided by the Commission before this matter proceeds further," Cox said. According to news reports over the weekend, the SEC issued subpoenas on Feb. 7 to columnists from two Dow Jones & Co. (DJ.N: Quote, Profile, Research) publications, asking for telephone records, e-mails and other documents related to online retailer Overstock.com Inc. (OSTK.O: Quote, Profile, Research) The SEC's investigation involves accusations by Overstock.com that stock-research firm Gradient Analytics Inc. negatively adjusted research after a hedge fund betting against the stock requested a change. © Reuters 2006. All Rights Reserved.

To: ravenseye who wrote (372)	2/27/2006 11:38:51 AM
From: StockDung	Read Replies (1) \| Respond to of 5673

Does Airborne Really Stave off Colds? An ABC News Investigation Found That the Product Might Not Work abcnews.go.com Feb. 27, 2006 — Americans catch a billion colds a year in this country and spend triple that — almost $3 billion — trying to treat them. But a "Good Morning America" drugstore investigation raises questions about one of America's favorite cold remedies — a product called Airborne. Victoria Knight-McDowell, the schoolteacher who developed Airborne, appeared on "The Oprah Winfrey Show." The popular talk-show host even endorsed it as a cold fighter. The product's ads are everywhere, and the company says its sales exceed $100 million. But now Airborne's CEO, Elise Donahue, is saying that the pill is not a cold remedy. "I would never sit here and tell you that it's a cure for the common cold," she said. "We don't know if Airborne is a … cure for the common cold. What Airborne does is it helps your body build a healthy immune system. When you have a healthy immune system, then it allows your body, on its own, to fight off germs." Donahue said the best proof that the product works was that 40,000 customers contact the company every year. But a number of medical experts and watchdog groups are skeptical that Airborne prevents or cures colds. "Simply washing your hands during cold and flu season is a much more effective way of preventing colds," said David Kroll, a pharmacologist at Duke University Medical School. Yet the Airborne box tells users to take the product at the first sign of a cold. An Airborne ad testimonial called it a miracle cold buster. And the company said in a news release Airborne would get rid of most colds in one hour. "I'm not commenting on that particular press release," Donahue said. "I wasn't with the company then." Airborne said that a double-blind, placebo-controlled study was conducted with "care and professionalism" by a company specializing in clinical trial management, GNG Pharmaceutical Services. GNG is actually a two-man operation started up just to do the Airborne study. There was no clinic, no scientists and no doctors. The man who ran things said he had lots of clinical trial experience. He added that he had a degree from Indiana University, but the school says he never graduated. "I would not define that then as a clinical trial," Kroll said. Airborne insists the results are valid, but the company is removing all references to the study from its Web site and packaging. "We found that it confused consumers," Donahue said. "Consumers are really not scientifically minded enough to be able to understand a clinical study." Now, Airborne is phasing in new packaging. Before, the box said that Knight-McDowell had created it because she was "sick of catching colds." Now, it says she created Airborne because she "needed help supporting her immune system." The word "cold" no longer appears on the new package or in the advertising. All the new packages will be on store shelves by this summer.

To: ravenseye who wrote (372)	3/18/2006 3:42:40 PM
From: ravenseye	Respond to of 5673

Libby lawyers subpoena reporters, news organizations Boston Globe, United States - Mar 17, 2006 ... The Times confirmed subpoenas to the newspaper and former reporter Judy Miller. NBC confirmed the subpoena to Russert.

To: ravenseye who wrote (372)	3/18/2006 3:43:25 PM
From: ravenseye	Respond to of 5673

Police blotter: Judge orders Gmail disclosure By Declan McCullagh Staff Writer, CNET News.com Published: March 17, 2006, 4:00 AM PST "Police blotter" is a weekly News.com report on the intersection of technology and the law. What: In a lawsuit brought by the Federal Trade Commission, a subpoena is sent to Google for the complete contents of a Gmail account, including deleted e-mail messages. This is unrelated to the Department of Justice's own subpoena to Google for search terms and excerpts from its search database. When: U.S. Magistrate Judge Elizabeth Laporte in San Francisco ruled on Jan. 31 and March 13. Outcome: Judge grants subpoena and orders that all e-mail messages, including deleted ones, be divulged. ... news.com.com